poloxalene has been researched along with Coronary Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrahams, SL; Buddemeier, K; Ennis, B; Hubbell, JP; Hursey, TL; Moy, J; Parrillo, JE; Rodriguez, ER; Schaer, GL | 1 |
Islamov, BI; KobrinskiÄ, EM; Lubiako, AA; MaevskiÄ, EI; Vorob'ev, SI | 1 |
2 other study(ies) available for poloxalene and Coronary Disease
Article | Year |
---|---|
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
Topics: Animals; Chemotaxis, Leukocyte; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Gases; Heart; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Neutrophils; Poloxalene; Ventricular Fibrillation; Ventricular Function, Left | 1994 |
[Effect of proxanols on electromechanical coupling in the myocardium and their contribution to protection against ischemia by fluorocarbon emulsions].
Topics: Animals; Cardiovascular Agents; Coronary Disease; Emulsions; Fluorocarbons; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Contraction; Poloxalene; Polyethylene Glycols; Rabbits; Ranidae; Rats | 1987 |